Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -1.12% | -9.25% | +167.00% |
Apr. 18 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
Mar. 06 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- Analyst Reco.